PATENT CLAIM ANALYSIS

Application Number: 15874674
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-09
Patent Classification: ["424", "093700"]

Abstract:
The present invention relates to treatment of pulmonary fibrosis with umbilical mesenchymal stem cell.

Claim (Index 2):
The method of  claim 1 , wherein the UMSCs are obtained from Wharton's Jelly.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14363814', '12184695', '14303748', '11696039', '13100528']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7330890882813748
- 35 USC 102 Novelty (BERT): 0.5192963018025595
- Combined Prediction Score: 0.7117098096334933
- Mean Citation Score: 238.89464200000003
- Max Citation Score: 254.12766
- Similarity Product: 137.5628313379526

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test